Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,566.50
+16.10 (1.04%)
Nov 17, 2025, 3:29 PM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 213.37 billion as of November 17, 2025. Its market cap has increased by 21.34% in one year.
Market Cap
213.37B
Enterprise Value
240.63B
Revenue
29.86B
Ranking
n/a
PE Ratio
51.44
Stock Price
1,566.50
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 213.37B, an increase of 157.98%. That is a compound annual growth rate of 11.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 211.18B | 12.93% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | 78.75B | 20.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.23T |
| Divi's Laboratories | 1.73T |
| Cipla | 1.24T |
| Apollo Hospitals Enterprise | 1.07T |
| Zydus Lifesciences | 940.58B |
| Mankind Pharma | 935.76B |
| Aurobindo Pharma | 718.39B |
| Fortis Healthcare | 707.92B |